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Abstract—A prototype of a low-cost phototherapy
light system (LPLS) was deployed by the Ateneo
Innovation Center (AIC) at a public hospital in Metro
Manila, Philippines. It underwent clinical investiga-
tion for two years under the supervision of licensed
physicians in a public tertiary hospital.
This paper presents the process of upgrading the
LPLS in order to enhance capabilities and improve
efficiency yet remain affordable. The following features
were added: (1) a visual and auditory monitoring
system in order to remotely oversee the infant from
the nurse station; (2) an automation system that
stores data about the device’s light intensity and bulb
temperature and records ambient humidity; (3) an
alarm system that activates the warning lights if sensor
readings are in critical level and if the bulbs need to
be replaced; and (4) a time setting to manually set
the time of operation and automatically turn-off the
device as programmed
The upgrades increased the system’s cost but it re-
mained cheaper than the ones commercially available.
For deployment in remote or off-grid hospitals, the
system was equipped with a solar-powering provision.
Index Terms—Phototherapy, neonatal jaundice,
sensing and remote monitoring, irradiance and am-
bient temperature and humidity, neonatal care.
I. INTRODUCTION
NEONATAL jaundice is a condition in infantscharacterized by the presence of high level of
bilirubin. Increased levels of serum bilirubin cause
irreversible brain damage and kernicterus in infants.
Jaundice occurs in the first two weeks of life in
25% to 60% of full-term newborns, and in 80% of
preterm newborns [1].
Treatment for jaundice was discovered serendip-
itously in 1957 by an observant nursing sister in
United Kingdom. The nun reported that the in-
fants whose crib was located in the nursery area
exposed to sunlight had their jaundice fade [2].
Exposing the baby directly to sunlight is still being
practiced. There are disadvantages to this practice:
harmful intensity of sunlight rays that can cause
acute erythema or sunburn, risk of dehydration, and
ultraviolet ray exposure that can cause skin damage,
skin cancer and eye damage, among others [3][4][5].
A low-cost phototherapy design that filters UV
from sunlight was recently published [6]. However,
sunlight is not always available during rainy days or
in the evening. If present, it is harmful to the skin
for most time of the day. Thus, this design failed to
optimize sun exposure and treatment.
Phototherapy remains the most frequently used
treatment when serum bilirubin levels exceed phys-
iological limits. The most important intervention for
infants with severe hyperbilirubinemia is immediate
exposure to phototherapy. It converts bilirubin into
water soluble photo-products that can bypass the
hepatic conjugating system and be excreted without
further metabolism. The clinical response to pho-
totherapy depends on the efficacy of the photother-
apy device, as well as the infant’s rates of bilirubin
production and elimination [7].
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Phototherapy can be delivered using several types
of conventional light sources, including daylight,
white or blue fluorescent bulbs and filtered halogen
bulbs. The efficacy and ability of these light sources
to provide intensive phototherapy vary widely. Some
light sources cannot be too close to the infant due to
high heat production and unstable broad wavelength
light output. In recent years, a new type of light
source, light-emitting diodes (LEDs), has been de-
veloped and studied as possible light sources for the
phototherapy. LEDs are power efficient, portable,
with low heat production, not heavy and have a
longer life span [2]. Blue LEDs emit a high intensity
narrow band of blue light overlapping the peak
spectrum of bilirubin breakdown resulting in poten-
tially shorter treatment time. These characteristics
of LEDs make them an optimal light sources for a
phototherapy device [8].
Phototherapy, despite being the recommended
standard of treatment for hyperbilirubinemia, is pro-
hibitive due to its high cost and expensive replace-
ment bulbs. In the United States, a second-hand
phototherapy light unit costs roughly US$2,000 and
a brand new unit is US$3,000. The treatment cost
ranged from US$800 to US$1,000 depending on the
severity of the infant’s condition. In the Philippines,
a brand-new phototherapy unit can cost PhP 150,000
(approximately US$3,000) depending on the quality
and efficiency of the unit. The treatment is simi-
larly costly. For instance, in one private provincial
hospital in the Philippines, treatment costs around
$16/day. It is likely that not all hospitals and health
units have ready access to phototherapy units finan-
cially and logistically. Where it is available in public
settings, anecdotes point to too few units available
causing patients to share units and a long queue for
using the device. This in turn leads to sub-optimal
exposure time and poorer outcomes.
Varied designs of phototherapy light units have
been tried out to address concern with cost and
portability, among others.
A portable and low-cost phototherapy blanket
uses 200 blue LED light bulbs to provide light
therapy to jaundiced infants. Its flexible photovoltaic
panel harnesses solar energy to power the blanket’s
battery, eliminating the need for electrical power
sources [9].
The Brezinski’s Bili-Hut phototherapy design is a
battery-powered pop-up tent lined with LEDs. It is
collapsible, highly portable, can fit into a shipping
tube yet big enough for a newborn to fit inside
comfortably. The LEDs that line its inner surface
are arranged in a radial array, and can shine the
right kind of blue light at the right intensity over
a baby’s entire body. All the parts are off-the-shelf.
The interior lining, for example, is made from a
material used for hydroponic gardening. This design
can run off 12-volt power [10].
A light-up pajama for jaundice treatment uses
polymer optical fibers to weave and bend at
just the right angle around perpendicularly ar-
ranged polyester threads. When connected to LEDs,
this generates the right amount of light, emitting
it throughout the fabric with constant intensity
[11][12]. However, Waltz (2017) cited that wearable
medical devices cannot compete with conventional
phototherapy light units because they were found
very difficult to be certified by regulators [11].
The above-mentioned designs are all imported.
Thus, busted bulbs may not be easily replaceable
and local technicians might not be able to repair
them. In this light, the AIC made a prototype that
is locally designed and less costly - the low cost
phototherapy light system or LPLS. However, there
are some concerns that emerged during its clinical
trial.
First, the light intensity of light-emitting diodes
(LEDs) deteriorated over time. This was seen in
the phototherapy prototype designed and deployed
by AIC in a public hospital in Metro Manila. The
readings reflected a decrease in irradiance from
84 to 59.40 microwatt per square centimeter per
nanometer, which was around 30% decrease, after
a three-year span [13]. Similarly, the wavelength
decreased from 462.1 nm to 457.15 nm which is
still within the acceptable range.
Another concern was that phototherapy light units
are mainly run by electricity, making it dependent
on the stability of electrical lines. When power
supply is intermittent or cut-off, the phototherapy
is disabled.
AIC locally designed a more efficient photother-
apy light unit with the intention to address the above
concerns. The upgraded design is affordable, with
components that are readily available in the local
market, and with technical design that is understand-
able for local technicians to trouble shoot and repair.
II. METHODOLOGY
This is a design and engineering study and hence
does not require prior ethical approval or ethics
clearance. This study was partially funded by Ate-
neo de Manila University, where the authors are
affiliated with, so there is no conflict of interest to
be declared.
We conceptualized the design of the low-cost
phototherapy light system (LPLS) shown in Fig. 1.
We identified the components to be used, learned
about operating them then canvassed and compared
the prices and efficiency. We chose and purchased all
equipment and materials needed and tested if every-
thing was functioning well: LED bulbs, solar panel,
batteries, charge controllers, DC-AC converters, and
electrical cable. In fabricating the LPLS, we used
20 pieces of 3-watt LED blue bulb, one 10-watt
computer fan with an AC to DC power adaptor,
roller base, adjustable iron stand, fuse, wires and
switches. We conducted a stress test by running
it continuously for 72 hours and we monitored
and recorded the wavelength, irradiance, and power
consumption.
Fig. 1. Block diagram of the Low-cost Phototherapy Light
System.
We made another unit to integrate intelligent sen-
sor and monitoring system. We called this upgraded
prototype as the Improved Low-cost Phototherapy
Light System or ILPLS.
III. IMPROVED LOW-COST PHOTHOTHERAPY
LIGHT SYSTEM
The ILPLS was designed to have the same func-
tions as the initial prototype. It was made to meet the
clinical needs using low-cost and locally available
components. The main components were the eight
pieces of 7-watt LED blue spotlight, which are more
robust and have the same cost as the 3-watt bulbs.
The wavelength was within the 400 - 500 nanome-
ters (peak at 460nm) which are specifically used
for administering phototherapy [14]. The measured
irradiance was three times stronger than that of the
3-watt bulb. The design of an 8-bulb unit exceeded
the total irradiance of the previous unit. The bulbs
were positioned alongside each other at a distance
of 13 centimeters apart (from center to center). This
engineering design made the light beams overlap by
43% resulting to a more intensified lighting. There
is an 11% intersection of light beams coming from
the bulbs positioned across each other, which are 22
centimeters apart. The 22-centimeter distance was
an engineering trade-off to give way to the fans that
provide fail-safe mechanism. Fig. 2 shows the LED
array.
Fig. 2. LED array with two ventilation fans.
Despite the distance, light intensity in the area
covered by overlapping beams still fell within the
range of required irradiance for jaundice treatment.
We also purposely designed the LED array so
the irradiation patterns overlapped in the exposure
area covering 150% of the 45-centimeter average
infant length. Light intensity was determined with a
photodetector that was calibrated using the RS PRO
ISM410. We made sure that the average intensity
exceeded the minimum needed by an engineering
margin of 300% to accommodate any changes in
performance.
These bulbs were enclosed in a plastic basin with
an acrylic cover. We also installed two units of 3-
watt computer fans (12Vdc) to increase the fail-safe
mechanism. We put a camera that can give visual
monitoring to baby’s condition and video records
it and a microphone that can remotely monitor
infant’s audio or voice at the nurse station. We
assembled the intelligent system and developed the
codes to be used for the microcontrollers, sensors
and actuators. We calibrated and tested them for
accuracy. The monitoring system will report, if the
irradiation levels diminish too much, necessitating
an LED replacement. We made a provision such
that the system can accept pre-set values for ambi-
ent temperature. Afterwards, the intelligent system’s
PCB layout and housing were designed and made.
The whole system was supported by a galvanized
iron stand with an adjustable height and movable
base.
We tested the unit for durability by running it
continuously for five days, non-stop, and no signifi-
cant issues were encountered. The block diagram of
ILPLS is shown in Fig. 3.
Fig. 3. Block diagram of the improved low-cost phototherapy
light system.
IV. RESULTS AND DISCUSSION
We had successfully wired an intelligent sys-
tem for ILPLS unit using light-dependent resis-
tors (LDRs), temperature and humidity sensors,
microcontrollers, microphone, camera and internet
connection. The microphone and camera remotely
monitor the infant’s audio and visually monitor the
baby’s condition. We devised a way to maintain and
keep things in check through the calibrated pho-
tosensor for the light intensity, temperature sensor
of the light bulbs and the ambient humidity. The
light intensity sensor is used to monitor the LED
intensity which can detect deterioration or damage
to the LEDs. The intelligent sensors can also detect
surrounding temperature and humidity and trigger
alarm system when the readings go beyond the set
threshold.
A commercial spectrometer was used to measure
the right wavelength of the LEDs. Using Ocean
Optics Model USB 4000, we were able to obtain
20.61 nm (437.38 nm to 457.68 nm) wavelength
at full width half maximum (FWHM) and peak
wavelength at 447.68 nanometers.
The ILPLS, like the LPLS and the commer-
cial phototherapy unit, emitted more than the re-
quired minimum irradiance of 30 microwatt/square-
centimeter/nanometer for effective treatment. Using
RS PRO ISM 410 in measuring irradiance of the
three different units (Table 1), we can see that the
ILPLS has the strongest irradiance. Notice that its
irradiance is three times higher than the required
minimum value. This is to ensure that the light
intensity, even if it would degrade 30% in three
years (like what was observed during clinical trial),
would remain twice the required strength. LPLS and
ILPLS are also more energy-efficient, which makes
provision of solar powering less costly and more
feasible.
In Table 1, we presented the differences of the
three phototherapy units.
We were able to run the ILPLS for 10 hours
powered by two 50-ampere-hour commercial lead-
acid car battery that were pre-charged by two 50-
watt solar panels. In order to run the unit for 24
hours, five car batteries or 250-ampere-hour am-
pacity and five solar panels would be needed. We
can implement a battery swapping system to ensure
continuous operation of the unit. It would entail
charging of five batteries while the other five batter-
ies are in use. This solar photovoltaic set-up using
a ten-battery swapping system costs about $1,250.
Aside from solar-powering, a pedal-powered battery
charging could also be used and its cost is almost
the same. This alternative power source where one
pedals a bicycle attached to an alternator can charge
batteries even at night time. The additional cost for
these alternative power sources enables deployment
of the phototherapy system in off-grid hospitals
and adds value of treatment accessibility to infants
with jaundice who live in far flung areas without
electrical service.
During the stress test of continuous 120-hour op-
eration, the ILPLS bulbs’ temperature ranged from
35.8◦C to 39.0◦C, which is an acceptable range,
at an ambient average temperature of 32.5◦C. No
issues were encountered at all.
The upgrades made the ILPLS more expensive
than the initial prototype but remained significantly
cheaper than the commercial unit. Having been
designed and fabricated locally, availability of spare
TABLE I
COMPARISON OF PROTOTYPES AND A
COMMERCIAL UNIT
Parameters LPLS ILPLS CommercialUnit
Light Bulb Twenty3-watt LED
Eight
7-watt LED
Five
20-watt
Fluorescent
Wavelength 462.1 nm to476.4 nm
437.8 nm to
458.48 nm
(5-white,
2-blue)
Irradiance
at 30 cm
Distance
84
µW/cm2/nm
90
µW/cm2/nm
70
µW/cm2/nm
Total
Power 75 watts 90 watts 400 watts
Ventilation One fan Two fans Air-cooled
Unit Cost PhP 20,000 PhP 35,000 PhP 150K
Sensor &
Monitoring
System
None Yes None
parts is almost always assured. Manual of operation
comes with the unit to guide the user for its opera-
tion, trouble shoot and repair.
V. CONCLUSION AND RECOMMENDATIONS
The study of Bagunu and Perez (2018) revealed
the effectiveness of the first prototype of the LPLS in
treating fifty (50) infants with jaundice. Their study
revealed that after 24 hours of exposure, adjusted
mean bilirubin levels of those who underwent LED
phototherapy was significantly lower as compared to
conventional phototherapy (17.27 ± 2.31 mg/dl ver-
sus 18.64 ± 2.81 mg/dl, p=0.000). After 48 hours,
there was consistently lower bilirubin in the exper-
imental group (13.37 ± 2.213 mg/dl versus 15.4 ±
2.496 mg/dl, p=0.000) and there were no reported
side effects in both groups. They concluded that
use of LED phototherapy showed significantly better
bilirubin-lowering effect. The improved prototype
(ILPLS), which was similar to the first one but used
LED spotlights that emitted greater irradiance, could
offer faster treatment. The system’s heat production
was found within tolerable level so as not to pose
any risks on the infant.
The intelligent sensor and monitoring system was
successfully integrated into the phototherapy light
system without affecting the unit’s optimal func-
tioning. The camera system is intended to provide
digital records of the patient ID, time stamp, unit
tag, audio tags by medical personnel, location of
the phototherapy that can readily interface with
nursing station and hospital medical records. The
smart camera was able to transmit images and
sounds within the 10-meter radius in a laboratory
setting, despite the presence of walls, demonstrating
that data collection at nearby stations is possible.
This approach is scalable and useful to situations
where multiple phototherapy units are operated at
the same time, the data of the ongoing phototherapy
can get recorded easily, serving as a complement
to the nurses records. Four photosensors or light-
dependent resistors (LDRs) enabled provision of
more accurate light intensity readings, after deter-
mining ambient lighting that may interfere with the
phototherapy light intensity values. The two-in-one
sensor also indicated temperature and humidity. The
cameras can be used as a backup intensity monitor,
thus application is under development. All readings
were stored in a system SD card. The timer setting
and alarm system worked as programmed.
The careful selection of spare parts made ILPLS
75% cheaper than the commercial unit despite the
additional features that were included. Alternative
power sources opened possible deployment of the
unit to off-grid communities. The mock set-up of
the ILPLS is found in Figure 4.
Fig. 4. Mock set-up of the improved low-cost phototherapy light
system.
We recommend that deployment of ILPLS in hos-
pitals can be done to find out its actual performance
and further test its durability. The efficacy of the
intelligent sensors and monitoring system can also
be investigated on the field and the ease of use
can be looked into. Further research can be done
to explore ways to prevent or slow down weakening
of LED lights’ intensity and wavelength over time.
Consultation and discussion with medical practi-
tioners can provide valuable input for its further
development.
We also recommend cross-calibration of the Sili-
con photodiodes used in monitoring with this cali-
brated detector, including the Webcam Silicon pho-
todiodes. A simple application averages the light
intensity over groups of pixels and this output is
another intensity monitor. This way we can gather
the average values of the exposure from over the
infant’s body. Each unit is scanned for performance
and calibrated against the reference photometer.
Given the importance of having a digital record
of treatment for patient records, hospital operations,
and PhilHealth payment, we anticipate the further
IT that will enhance the system usefulness without
adding extra cost. In an expanded prototype, using
a camera, we can use image recognition to record
a patient label, capture images of infant’s posture
during treatment measure, total exposure, nurse at-
tendant and LED readout at the unit.
Calibrated open source apps in hand-held devices
can also be used to detect the following: (1) target
color of the infant’s skin that will indicate improve-
ment in health condition, (2) irradiance of light
to know if the bulbs are functioning properly for
optimal healing capacity, (3) temperature inside the
system to determine the conducive heat level for the
infant. A smart phone can be used to access these
apps and an LCD to display the readings. There is
more room for technical upgrade of ILPLS. Yet, as it
is, it already offers greater accessibility to jaundice
treatment in an affordable way with more helpful
features and an alternative power source for off-grid
health facilities.
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